Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 11, Pages e0142582
Publisher
Public Library of Science (PLoS)
Online
2015-11-14
DOI
10.1371/journal.pone.0142582
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls
- (2015) Jon Infante et al. NEUROBIOLOGY OF AGING
- Overexpression of blood microRNAs 103a, 30b, and 29a in L-dopa-treated patients with PD
- (2015) A. Serafin et al. NEUROLOGY
- The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system
- (2015) K. Ray Chaudhuri et al. PARKINSONISM & RELATED DISORDERS
- CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
- (2015) Changqin Liu et al. PARKINSONISM & RELATED DISORDERS
- Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson’s disease
- (2015) Jose A. Santiago et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasma Epidermal Growth Factor Decreased in the Early Stage of Parkinson’s Disease
- (2015) Qian-Wen Jiang et al. Aging and Disease
- What can biomarkers tell us about cognition in Parkinson's disease?
- (2014) Brit Mollenhauer et al. MOVEMENT DISORDERS
- System-based approaches to decode the molecular links in Parkinson's disease and diabetes
- (2014) Jose A. Santiago et al. NEUROBIOLOGY OF DISEASE
- Accuracy of Parkinson disease diagnosis unchanged in 2 decades
- (2014) A. H. Rajput et al. NEUROLOGY
- Unbiased Approaches to Biomarker Discovery in Neurodegenerative Diseases
- (2014) Alice S. Chen-Plotkin NEURON
- Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease
- (2014) Jose A. Santiago et al. PLoS One
- A network approach to clinical intervention in neurodegenerative diseases
- (2014) Jose A. Santiago et al. TRENDS IN MOLECULAR MEDICINE
- Involvement of Endocytosis and Alternative Splicing in the Formation of the Pathological Process in the Early Stages of Parkinson’s Disease
- (2014) Anelya Kh. Alieva et al. Biomed Research International
- Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale
- (2013) P. Martinez-Martin et al. EUROPEAN JOURNAL OF NEUROLOGY
- Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease
- (2013) M. T. Pellecchia et al. EUROPEAN JOURNAL OF NEUROLOGY
- Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease
- (2013) Marina Picillo et al. JOURNAL OF NEUROLOGY
- Specific splice variants are associated with Parkinson's disease
- (2013) Jose A. Santiago et al. MOVEMENT DISORDERS
- Integrative Network Analysis Unveils Convergent Molecular Pathways in Parkinson's Disease and Diabetes
- (2013) Jose A. Santiago et al. PLoS One
- Shared dysregulated pathways lead to Parkinson's disease and diabetes
- (2013) Jose A. Santiago et al. TRENDS IN MOLECULAR MEDICINE
- Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson’s disease patients
- (2012) Maria Teresa Pellecchia et al. JOURNAL OF NEUROLOGY
- A molecular signature in blood identifies early Parkinson’s disease
- (2012) Leonid Molochnikov et al. Molecular Neurodegeneration
- Biosignatures for Parkinson’s Disease and Atypical Parkinsonian Disorders Patients
- (2012) Judith A. Potashkin et al. PLoS One
- Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease
- (2011) Madalena Martins et al. PLoS One
- The Parkinson Progression Marker Initiative (PPMI)
- (2011) Kenneth Marek et al. PROGRESS IN NEUROBIOLOGY
- Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease
- (2010) Alice S. Chen-Plotkin et al. ANNALS OF NEUROLOGY
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The MoCA: Well-suited screen for cognitive impairment in Parkinson disease
- (2010) J. C. Dalrymple-Alford et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now